Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal
OwnerAndrew Nash, Pino Maccarone +2inventors
InventorsAndrew Nash, Pino Maccarone, Paul Egan, Ian Wicks
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to a method for the treatment and/or prophylaxis of conditions arising from or otherwise associated with aberrations in hormone signalling. More particularly, the present invention contemplates a method for the treatment and/or prophylaxis of conditions, the amelioration of symptoms of which, are facilitated by an over-expression of a gene encoding a suppressor of cytokine signalling molecule. The present invention further contemplates agents useful for the prophylaxis and/or treatment of such renditions in mammals including humans.
Claims37
A method for modulating cytokine or hormone signaling in an animal, said method comprising regulating expression of a genetic sequence encoding a SOCS protein or its derivative or homolog in said animal.
A method of modulating cytokine or hormone signalling in an animal and in particular a human, said method comprising up-regulating expression of a genetic sequence encoding a SOCS protein or increasing in said animal and wherein said SOCS protein comprises a protein:molecule interaction region such as but not limited to an SH2 domain, WD-40 repeats and/or ankyrin repeats, N-terminal of a SOCS box, wherein said SOCS box comprises the amino acid sequence:—
- X1X2X3X4X5X7X8X9X10X11X12X13X14X15X16[Xi]nX17X18X19X20X21X22X23[Xj]nX24X25X26X27X28
- wherein:
- X1 is L, I, V, M, A or P;
- X2 is any amino acid residue;
- X3 is P, T or S;
- X4 is L, I, V, M, A or P;
- X5 is any amino acid;
- X6 is any amino acid;
- X7 is L, I, V, M, F, Y or W;
- X8 is C, T or S;
- X9 is R, K or H;
- X10 is any amino acid;
- X11 is any amino acid;
- X12 is L, I, V, M, A or P,
- X13 is any amino acid;
- X14 is any amino acid;
- X15 is any amino acid;
- X16 is L, I, V, M, A, P, G, C, T or S;
- [Xi]n is a sequence of n amino acids wherein n is from 1 to 50 amino acids and wherein the sequence Xi may comprise he same or different amino acids selected from any amino acid residue;
- X17 is L, I, V, M, A or P;
- X18 is any amino acid;
- X19 is any amino acid;
- X20 is L, I, V, M, A or P;
- X21 is P;
- X22 is V, M, A, P or G;
- X23 is P or N;
- [Xj]n is a sequence of n amino acids wherein n is from 0 to 50 amino acids and wherein the Xj may comprise the same or different amino acids selected from any amino acid residue;
- X24 is L, I, V, M, A or P;
- X25 is any amino acid;
- X26 is any amino acid,
- X27 is Y or F;
- X28 is L, I, V, M, A or P.
A genetically modified animal having a mutation in one or both alleles of SOCS-1.
Use of an expression vector encoding a SOCS protein to facilitate over-expression of said SOCS protein in an animal cell.
Dependencies are inferred from the claim text.